Shandong Huabo Kaisheng Bio-tech

Shandong Huabo Kaisheng Bio-tech is a specialized pharmaceutical company based in China, focusing on the development and industrialization of complex injectable formulations. The company leverages advanced drug delivery systems, including long-acting microspheres, liposomes, and nanocrystals, to improve the therapeutic profile of existing drugs. Their pipeline primarily targets chronic and high-burden conditions such as type 2 diabetes, prostate cancer, and schizophrenia. Shandong Huabo Kaisheng operates a significant manufacturing base in Jinan, which is GMP-certified for the production of high-end generic and innovative injectables. In addition to its internal pipeline, the company provides CDMO services to partners seeking expertise in complex formulation development.